Phase II randomized trial of radiation therapy, cetuximab, and pemetrexed with or without bevacizumab in patients with locally advanced head and neck cancer. Read more about Phase II randomized trial of radiation therapy, cetuximab, and pemetrexed with or without bevacizumab in patients with locally advanced head and neck cancer.
Systematic evaluation of pembrolizumab dosing in patients with advanced non-small-cell lung cancer. Read more about Systematic evaluation of pembrolizumab dosing in patients with advanced non-small-cell lung cancer.
A phase I trial of panobinostat and epirubicin in solid tumors with a dose expansion in patients with sarcoma. Read more about A phase I trial of panobinostat and epirubicin in solid tumors with a dose expansion in patients with sarcoma.
What hides behind the MASC: clinical response and acquired resistance to entrectinib after ETV6-NTRK3 identification in a mammary analogue secretory carcinoma (MASC). Read more about What hides behind the MASC: clinical response and acquired resistance to entrectinib after ETV6-NTRK3 identification in a mammary analogue secretory carcinoma (MASC).
CA19-9 decrease at 8 weeks as a predictor of overall survival in a randomized phase III trial (MPACT) of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone in patients with metastatic pancreatic cancer. Read more about CA19-9 decrease at 8 weeks as a predictor of overall survival in a randomized phase III trial (MPACT) of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone in patients with metastatic pancreatic cancer.
Meta-analysis of stomatitis in clinical studies of everolimus: incidence and relationship with efficacy. Read more about Meta-analysis of stomatitis in clinical studies of everolimus: incidence and relationship with efficacy.
Can ovarian suppression with gonadotropin-releasing hormone analogs (GnRHa) preserve fertility in cancer patients? Read more about Can ovarian suppression with gonadotropin-releasing hormone analogs (GnRHa) preserve fertility in cancer patients?
Vitamin D and pancreatic cancer: a pooled analysis from the Pancreatic Cancer Case-Control Consortium. Read more about Vitamin D and pancreatic cancer: a pooled analysis from the Pancreatic Cancer Case-Control Consortium.
Randomized phase II study evaluating veliparib (ABT-888) with temozolomide in patients with metastatic melanoma. Read more about Randomized phase II study evaluating veliparib (ABT-888) with temozolomide in patients with metastatic melanoma.
Recommendations for standardized pathological characterization of residual disease for neoadjuvant clinical trials of breast cancer by the BIG-NABCG collaboration. Read more about Recommendations for standardized pathological characterization of residual disease for neoadjuvant clinical trials of breast cancer by the BIG-NABCG collaboration.
